Zymeworks Inc. (ZYME)
NASDAQ: ZYME · IEX Real-Time Price · USD
9.00
+0.24 (2.74%)
At close: May 2, 2024, 4:00 PM
8.80
-0.20 (-2.22%)
After-hours: May 2, 2024, 7:55 PM EDT
Zymeworks Revenue
Zymeworks had revenue of $50.46M in the twelve months ending March 31, 2024, down -88.69% year-over-year. Revenue in the quarter ending March 31, 2024 was $10.03M, a -71.81% decrease year-over-year. In the year 2023, Zymeworks had annual revenue of $76.01M, a decrease of -81.57%.
Revenue (ttm)
$50.46M
Revenue Growth
-88.69%
P/S Ratio
12.59
Revenue / Employee
$185,529
Employees
272
Market Cap
635.11M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 76.01M | -336.47M | -81.57% |
Dec 31, 2022 | 412.48M | 385.80M | 1,446.03% |
Dec 31, 2021 | 26.68M | -12.27M | -31.50% |
Dec 31, 2020 | 38.95M | 9.41M | 31.84% |
Dec 31, 2019 | 29.54M | -23.48M | -44.28% |
Dec 31, 2018 | 53.02M | 1.26M | 2.43% |
Dec 31, 2017 | 51.76M | 40.75M | 370.18% |
Dec 31, 2016 | 11.01M | 1.35M | 13.96% |
Dec 31, 2015 | 9.66M | 7.99M | 478.44% |
Dec 31, 2014 | 1.67M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Cross Country Healthcare | 2.02B |
Novavax | 983.71M |
Accolade | 414.29M |
Fulgent Genetics | 289.21M |
Quanterix | 122.37M |
Wave Life Sciences | 113.31M |
Jin Medical International | 19.82M |
ZYME News
- 9 hours ago - Lost Money on Zymeworks Inc.(ZYME)? Contact Levi & Korsinsky Regarding an Ongoing Investigation - Accesswire
- 20 hours ago - ATTENTION Zymeworks Inc. Investors: You May Have Been Affected by Fraud - Contact Levi & Korsinsky to Discuss Your Rights - Accesswire
- 3 days ago - Zymeworks Announces Participation in Upcoming Investor Conferences - GlobeNewsWire
- 4 days ago - SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zymeworks Inc. - ZYME - PRNewsWire
- 13 days ago - ATTENTION ZYME SHAREHOLDERS: Investors who Lost Money on Zymeworks Inc. are Urged to Contact Levi & Korsinsky about an Ongoing Investigation - Accesswire
- 14 days ago - ZYME ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Zymeworks Inc. - Accesswire
- 16 days ago - Levi & Korsinsky Reminds Shareholders of an Investigation into Zymeworks Inc. (ZYME) Regarding Potential Securities Fraud Allegations - Accesswire
- 20 days ago - Zymeworks Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Zymeworks (ZYME) - Accesswire